Apr 24, 2026
Accenture Invests in Iridius to Accelerate Compliance-First AI Adoption in Life Sciences
Accenture has made a strategic investment in Iridius, a company specializing in AI infrastructure designed to meet compliance requirements in regulated industries, particularly life sciences and pharmaceuticals. This partnership aims to enhance AI adoption in life sciences organizations while ensuring that compliance and auditability are integrated throughout the AI development process.The collaboration will leverage Accenture's extensive industry expertise alongside Iridius' AI-powered complian